🇺🇸 FDA
Pipeline program

Kapruvia 50 micrograms/mL solution for injection

KOR-PED-202

Phase 2 small_molecule active

Quick answer

Kapruvia 50 micrograms/mL solution for injection for Pruritus, Chronic Kidney Diseases is a Phase 2 program (small_molecule) at Fresenius Kabi Australia Pty Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Fresenius Kabi Australia Pty Limited
Indication
Pruritus, Chronic Kidney Diseases
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials